Startseite Testicular adrenal rest tumors in Indonesian boys with congenital adrenal hyperplasia
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Testicular adrenal rest tumors in Indonesian boys with congenital adrenal hyperplasia

  • Epifani A. Chandra ORCID logo , Agustini Utari ORCID logo EMAIL logo , Bas P.H. Adriaansen ORCID logo , Dineke Westra ORCID logo , Farah H. Ningrum ORCID logo , Antonius G. Santoso ORCID logo , Antonius E. van Herwaarden ORCID logo und Hedi L. Claahsen-van der Grinten ORCID logo
Veröffentlicht/Copyright: 20. Juni 2025

Abstract

Objectives

Male patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) are at risk of developing testicular adrenal rest tumors (TART), which are benign but an important cause of infertility. The limited medical infrastructure and lack of knowledge and awareness of 21OHD in Indonesia has contributed to missed or delayed diagnoses, leading to a reportedly low prevalence of 21OHD and an expected high rate of undiagnosed patients. In Indonesia, TART has not been widely reported, with only a single patient documented in a recent paper. This study aim was to define the potential risk factors for developing TART in Indonesian pediatric patients with 21OHD.

Methods

This cross-sectional study was conducted in 20 boys with genetically proven 21OHD (0–18 years old). All had pathogenic variants associated with 0 % or 0–1% residual enzymatic activity. Medical history, clinical characteristics, genetic analysis results, biochemical measurements, bone age, and scrotal ultrasonography (US) data were evaluated.

Results

In 5 of 20 patients (25 %), TART was detected by US. The patients with TART were mainly in puberty (p=0.014). Higher androstenedione levels and advanced bone age were associated with TART.

Conclusions

TART is an important complication in Indonesian patients with 21OHD presenting before or during puberty. Factors associated with TART are pubertal age and longstanding poor hormonal control. Early diagnosis and optimization of treatment may help to prevent TART development and consequently improve fertility in these patients.


Corresponding author: Agustini Utari, MD, PhD, Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Diponegoro University, Prof. Mr. Sunario Street, Semarang, 50275, Indonesia; and Center for Biomedical Research (CEBIOR), Faculty of Medicine, Diponegoro University, Prof. Mr. Sunario Street, Semarang, 50275, Indonesia, E-mail:

Funding source: Faculty of Medicine Grant, Diponegoro University

Award Identifier / Grant number: 751/UN7.F4/PP/IV/2023

Funding source: European Society for Paediatric Endocrinology (ESPE) sponsored program “ESPE Visiting Professorship” supported by Pfizer

Acknowledgments

The authors appreciate the study participants, CEBIOR technicians for helping in collecting the samples, and Radboud university medical center clinical chemists and genome diagnosticians for their technical support in biochemical measurement and genetic analysis.

  1. Research ethics: Ethical approval was obtained from the Medical Research Ethical Committee of Dr. Kariadi Central General Hospital (No. 1486/EC/KEPK-RSDK/2023) granted on 7 July 2023. This study was conducted according to the Declaration of Helsinki (as revised in 2013).

  2. Informed consent: Written consent was acquired from the parents after a full explanation of the purpose and nature of all procedures in the study.

  3. Author contributions: EA, AU, HC, and AG were involved in conceptualizing the study. EA and AU collected the data, FH analyzed the radiological examination, BA and AH measured and analyzed the hormonal examination, and DW supervised genetic analyses and reported the results. All authors critically reviewed and revised the manuscript. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: This work was supported by the Faculty of Medicine Grant, Diponegoro University (Number 751/UN7.F4/PP/IV/2023) and collaboration through the European Society for Paediatric Endocrinology (ESPE) sponsored program “ESPE Visiting Professorship” supported by Pfizer.

  7. Data availability: Not applicable.

References

1. Claahsen-van der Grinten, HL, Speiser, PW, Ahmed, SF, Arlt, W, Auchus, RJ, Falhammar, H, et al.. Congenital adrenal hyperplasia – current insights in pathophysiology, diagnostics, and management. Endocr Rev 2022;43:91–159. https://doi.org/10.1210/endrev/bnab016.Suche in Google Scholar PubMed PubMed Central

2. Engels, M. Congenital adrenal hyperplasia about causes and consequences. Nijmegen, the Netherlands: Ipskamp printing, Enschede; 2018.Suche in Google Scholar

3. The World Bank. Birth rate, crude (per 1,000 people) - Indonesia. [Online]. https://data.worldbank.org/indicator/SP.DYN.CBRT.IN?locations=ID [Accessed 19 Apr 2024].Suche in Google Scholar

4. The World Bank. Population, total - Indonesia. [Online]. https://data.worldbank.org/indicator/SP.POP.TOTL?locations=ID [Accessed 19 Apr 2024].Suche in Google Scholar

5. Armstrong, K, Benedict Yap, A, Chan-Cua, S, Craig, ME, Cole, C, Chi Dung, V, et al.. We all have a role to play: redressing inequities for children living with CAH and other chronic health conditions of childhood in resource-poor settings. Int J Neonatal Screen 2020;6:76. https://doi.org/10.3390/ijns6040076.Suche in Google Scholar PubMed PubMed Central

6. Claahsen-Van der Grinten, H, Otten, B, Stikkelbroeck, M, Sweep, F, Hermus, A. Testicular adrenal rest tumours in congenital adrenal hyperplasia. J Clin Endocrinol Metab 2009;23:209–20.10.1016/j.beem.2008.09.007Suche in Google Scholar PubMed

7. Engels, M, Span, PN, van Herwaarden, AE, Sweep, FC, Stikkelbroeck, NM, Claahsen-van der Grinten, HL. Testicular adrenal rest tumors: current insights on prevalence, characteristics, origin, and treatment. Endocr Rev 2019;40:973–87. https://doi.org/10.1210/er.2018-00258.Suche in Google Scholar PubMed

8. Aycan, Z, Bas, VN, Cetinkaya, S, Yilmaz Agladioglu, S, Tiryaki, T. Prevalence and long‐term follow‐up outcomes of testicular adrenal rest tumours in children and adolescent males with congenital adrenal hyperplasia. Clin Endocrinol 2013;78:667–72. https://doi.org/10.1111/cen.12033.Suche in Google Scholar PubMed

9. Cakir, E, Mutlu, FS, Eren, E, Paşa, AO, Sağlam, H, Tarim, O. Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia. J Clin Res Pediatr Endocrinol 2012;4:94–100. https://doi.org/10.4274/jcrpe.563.Suche in Google Scholar PubMed PubMed Central

10. Claahsen-van Der Grinten, HL, Dehzad, F, Kamphuis-van Ulzen, K, De Korte, CL. Increased prevalence of testicular adrenal rest tumours during adolescence in congenital adrenal hyperplasia. Horm Res Paediatr 2014;82:238–44. https://doi.org/10.1159/000365570.Suche in Google Scholar PubMed

11. Claahsen-van der Grinten, HL, Sweep, FC, Blickman, JG, Hermus, AR, Otten, BJ. Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol 2007;157:339–44. https://doi.org/10.1530/eje-07-0201.Suche in Google Scholar PubMed

12. Dumic, M, Duspara, V, Grubic, Z, Oguic, SK, Skrabic, V, Kusec, V. Testicular adrenal rest tumors in congenital adrenal hyperplasia – cross-sectional study of 51 Croatian male patients. Eur J Pediatr 2017;176:1393–404. https://doi.org/10.1007/s00431-017-3008-7.Suche in Google Scholar PubMed

13. Kim, MS, Goodarzian, F, Keenan, MF, Geffner, ME, Koppin, CM, De Filippo, RE, et al.. Testicular adrenal rest tumors in boys and young adults with congenital adrenal hyperplasia. J Urol 2017;197:931–6. https://doi.org/10.1016/j.juro.2016.09.072.Suche in Google Scholar PubMed PubMed Central

14. Kocova, M, Janevska, V, Anastasovska, V. Testicular adrenal rest tumors in boys with 21-hydroxylase deficiency, timely diagnosis and follow-up. Endocr Connect 2018;7:544. https://doi.org/10.1530/ec-18-0097.Suche in Google Scholar PubMed PubMed Central

15. Martinez-Aguayo, A, Rocha, A, Rojas, N, García, C, Parra, R, Lagos, M, et al.. Testicular adrenal rest tumors and Leydig and Sertoli cell function in boys with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 2007;92:4583–9. https://doi.org/10.1210/jc.2007-0383.Suche in Google Scholar PubMed

16. Meena, H, Jana, M, Singh, V, Kabra, M, Jain, V. Growth pattern and clinical profile of Indian children with classical 21-hydroxylase deficiency congenital adrenal hyperplasia on treatment. Indian J Pediatr 2019;86:496–502. https://doi.org/10.1007/s12098-018-02848-6.Suche in Google Scholar PubMed

17. Schröder, MAM, Neacşu, M, Adriaansen, BPH, Sweep, FCGJ, Ahmed, SF, Ali, SR, et al.. Hormonal control during infancy and testicular adrenal rest tumor development in males with congenital adrenal hyperplasia: a retrospective multicenter cohort study. Eur J Endocrinol 2023;189:460–8. https://doi.org/10.1093/ejendo/lvad143.Suche in Google Scholar PubMed

18. Adriaansen, BP, Schröder, MA, Span, PN, Sweep, FC, van Herwaarden, AE, Claahsen-van der Grinten, HL. Challenges in treatment of patients with non-classic congenital adrenal hyperplasia. Front Endocrinol 2022;13:1064024. https://doi.org/10.3389/fendo.2022.1064024.Suche in Google Scholar PubMed PubMed Central

19. Falhammar, H, Nyström, HF, Ekström, U, Granberg, S, Wedell, A, Thorén, M. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur J Endocrinol 2012;166:441–9. https://doi.org/10.1530/EJE-11-0828.Suche in Google Scholar PubMed PubMed Central

20. Chandra, EA, Utari, A, Adriaansen, BPH, Claahsen-van der Grinten, HL. Testicular adrenal rest tumors in an Indonesian patient with congenital adrenal hyperplasia: a first case report. Bali Med J 2024;14:214–8. https://doi.org/10.15562/bmj.v14i1.5447.Suche in Google Scholar

21. Al-Ghamdi, WM, Shazly, MA, Al-Agha, AE. Testicular adrenal rest tumors in children with congenital adrenal hyperplasia. Saudi Med J 2021;42:986. https://doi.org/10.15537/smj.2021.42.9.20210257.Suche in Google Scholar PubMed PubMed Central

22. Pulungan, A, Julia, M, Batubara, J, Hermanussen, M. Indonesian national synthetic growth charts. Acta Sci Paediatr 2018;1:20–34.Suche in Google Scholar

23. Claahsen-van der Grinten, HL, Stikkelbroeck, N, Falhammar, H, Reisch, N. Management of endocrine disease: gonadal dysfunction in congenital adrenal hyperplasia. Eur J Endocrinol 2021;184:R85–R97. https://doi.org/10.1530/EJE-20-1093.Suche in Google Scholar PubMed

24. Liu, Y, Chen, M, Liu, J, Mao, A, Teng, Y, Yan, H, et al.. Comprehensive analysis of congenital adrenal hyperplasia using long-read sequencing. Clin Chem 2022;68:927–39. https://doi.org/10.1093/clinchem/hvac046.Suche in Google Scholar PubMed

25. Nan, MN, Roig, R, Martínez, S, Rives, J, Urgell, E, Espinós, JJ, et al.. Comprehensive genetic testing of CYP21A2: a retrospective analysis in patients with suspected congenital adrenal hyperplasia. J Clin Med 2021;10:1183. https://doi.org/10.3390/jcm10061183.Suche in Google Scholar PubMed PubMed Central

26. Krone, N, Arlt, W. Genetics of congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metabol 2009;23:181–92. https://doi.org/10.1016/j.beem.2008.10.014.Suche in Google Scholar PubMed PubMed Central

27. Mendes-dos-Santos, CT, Martins, DL, Guerra-Júnior, G, Baptista, MTM, de-Mello, MP, de Oliveira, LC, et al.. Prevalence of testicular adrenal rest tumor and factors associated with its development in congenital adrenal hyperplasia. Horm Res Paediatr 2018;90:161–8. https://doi.org/10.1159/000492082.Suche in Google Scholar PubMed

28. Bouvattier, C, Esterle, L, Renoult-Pierre, P, de La Perrière, AB, Illouz, F, Kerlan, V, et al.. Clinical outcome, hormonal status, gonadotrope axis, and testicular function in 219 adult men born with classic 21-hydroxylase deficiency. A French national survey. J Clin Endocrinol Metab 2015;100:2303–13. https://doi.org/10.1210/jc.2014-4124.Suche in Google Scholar PubMed

29. Engels, M, Gehrmann, K, Falhammar, H, Webb, EA, Nordenström, A, Sweep, FC, et al.. Gonadal function in adult male patients with congenital adrenal hyperplasia. Eur J Endocrinol 2018;178:285–94. https://doi.org/10.1530/eje-17-0862.Suche in Google Scholar

30. Huneif, MA, Al Mutairi, M, AlHazmy, ZH, AlOsaimi, FK, AlShoomi, AM, AlGhofely, MA, et al.. Screening for testicular adrenal rest tumors among children with congenital adrenal hyperplasia at King Fahad Medical City, Saudi Arabia. J Pediatr Endocrinol Metab 2022;35:49–54. https://doi.org/10.1515/jpem-2021-0291.Suche in Google Scholar PubMed

31. Nermoen, I, Rørvik, J, Holmedal, SH, Hykkerud, DL, Fougner, KJ, Svartberg, J, et al.. High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21‐hydroxylase deficiency. Clin Endocrinol 2011;75:753–9. https://doi.org/10.1111/j.1365-2265.2011.04151.x.Suche in Google Scholar PubMed

32. Pierre, P, Despert, F, Tranquart, F, Coutant, R, Tardy, V, Kerlan, V, et al.. Adrenal rest tissue in gonads of patients with classical congenital adrenal hyperplasia: multicenter study of 45 French male patients. Ann Endocrinol 2012;73:515–22. https://doi.org/10.1016/j.ando.2012.09.005.Suche in Google Scholar PubMed

33. Reisch, N, Rottenkolber, M, Greifenstein, A, Krone, N, Schmidt, H, Reincke, M, et al.. Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency. J Clin Endocrinol Metab 2013;98:E1820–E6. https://doi.org/10.1210/jc.2012-3181.Suche in Google Scholar PubMed

34. Turcu, AF, Mallappa, A, Elman, MS, Avila, NA, Marko, J, Rao, H, et al.. 11-Oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-hydroxylase deficiency. J Clin Endocrinol Metab 2017;102:2701–10. https://doi.org/10.1210/jc.2016-3989.Suche in Google Scholar PubMed PubMed Central

35. Yu, MK, Jung, MK, Kim, KE, Kwon, AR, Chae, HW, Kim, DH, et al.. Clinical manifestations of testicular adrenal rest tumor in males with congenital adrenal hyperplasia. Ann Pediatr Endocrinol Metab 2015;20:155–61. https://doi.org/10.6065/apem.2015.20.3.155.Suche in Google Scholar PubMed PubMed Central

36. Delfino, M, Elia, J, Imbrogno, N, Argese, N, Mazzilli, R, Toscano, V, et al.. Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia: prevalence and sonographic, hormonal, and seminal characteristics. J Ultrasound Med 2012;31:383–8. https://doi.org/10.7863/jum.2012.31.3.383.Suche in Google Scholar PubMed

37. King, TF, Lee, MC, Williamson, EE, Conway, GS. Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency. Clin Endocrinol 2016;84:830–6. https://doi.org/10.1111/cen.13001.Suche in Google Scholar PubMed

38. Mazzilli, R, Stigliano, A, Delfino, M, Olana, S, Zamponi, V, Iorio, C, et al.. The high prevalence of testicular adrenal rest tumors in adult men with congenital adrenal hyperplasia is correlated with ACTH levels. Front Endocrinol 2019;10:335. https://doi.org/10.3389/fendo.2019.00335.Suche in Google Scholar PubMed PubMed Central

Received: 2025-01-12
Accepted: 2025-05-06
Published Online: 2025-06-20
Published in Print: 2025-08-26

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Endocrine treatment in Duchenne muscular dystrophy – current practices and future directions
  4. Reviews
  5. Pubertal induction therapy in pediatric patients with Duchenne muscular dystrophy
  6. Evaluating obesity and fat cells as possible important metabolic players in childhood leukemia
  7. Biological effects of recombinant human growth hormone therapy on metabolism in children with growth hormone deficiency: a review
  8. Original Articles
  9. The use of bisphosphonate and testosterone in young people with Duchenne muscular dystrophy: an international clinician survey
  10. Characterizing the metabolome of children with growth hormone deficiency
  11. Is L-dopa test effective in detecting adrenal insufficiency with preliminary diagnosis of growth hormone deficiency in children with short stature?
  12. Comparison of the clinical characteristics of children with Silver–Russell syndrome genetically confirmed or not and their response to growth hormone therapy: a national multicenter study
  13. Testicular adrenal rest tumors in Indonesian boys with congenital adrenal hyperplasia
  14. Oxidative stress in branched-chain organic acidemias using thiol-disulfide homeostasis
  15. Case Reports
  16. Delayed diagnosis of retroperitoneal paraganglioma in an 8-year-old boy with persistent hypertension: a case report and review of diagnostic challenges in pediatric secondary hypertension
  17. Pediatric iatrogenic Cushing’s syndrome: a series of seven cases induced by topical corticosteroid use
  18. Wolcott–Rallison syndrome: late-onset diabetes, multiple epiphyseal dysplasia, and acute liver failure – a case report
Heruntergeladen am 11.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2025-0026/html
Button zum nach oben scrollen